MARKET

BIO

BIO

Bio Rad Labs Inc
NYSE
246.27
+2.76
+1.13%
After Hours: 246.27 0 0.00% 16:45 05/14 EDT
OPEN
243.69
PREV CLOSE
243.51
HIGH
249.35
LOW
243.43
VOLUME
403.53K
TURNOVER
--
52 WEEK HIGH
343.12
52 WEEK LOW
211.43
MARKET CAP
6.59B
P/E (TTM)
40.57
1D
5D
1M
3M
1Y
5Y
1D
Bio-Rad resumed with an Outperform at RBC Capital
TipRanks · 8h ago
Top Bio-Tech Executive Makes Notable Move With Fresh Insider Stock Sale
TipRanks · 1d ago
Weekly Report: what happened at BIO last week (0504-0508)?
Weekly Report · 3d ago
A Look At Bio-Rad (BIO) Valuation After Q1 2026 Net Loss And Outlook Cut
Simply Wall St · 5d ago
Bio-Rad to Participate in Upcoming Investor Conferences
Barchart · 6d ago
Ariel Focus Fund Q1 2026 Performers And Detractors
Seeking Alpha · 05/08 01:15
Bio-Rad (BIO) Q2 2025 Earnings Call Transcript
The Motley Fool · 05/04 14:27
Unlocking Bio-Rad (BIO) International Revenues: Trends, Surprises, and Prospects
NASDAQ · 05/04 13:15
More
About BIO
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Webull offers Bio Rad Laboratories Inc stock information, including NYSE: BIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIO stock methods without spending real money on the virtual paper trading platform.